Intrauterine Blood Transfusion: Current Indications and Associated Risks | Zendy

Irene T.M. Lindenburg | Zendy; Inge L. van Kamp | Zendy; Dick Oepkes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intrauterine Blood Transfusion: Current Indications and Associated Risks

Author(s) -

Irene T.M. Lindenburg,

Inge L. van Kamp,

Dick Oepkes

Publication year - 2014

Publication title -

fetal diagnosis and therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.976

H-Index - 60

eISSN - 1421-9964

pISSN - 1015-3837

DOI - 10.1159/000362812

Subject(s) - medicine , anemia , obstetrics , complication , blood transfusion , pregnancy , parvovirus , fetus , intensive care medicine , surgery , immunology , virus , genetics , biology

Fetal anemia is a serious complication in pregnancy and associated with perinatal mortality and morbidity. During 25 years of worldwide experience with intravascular intrauterine blood transfusion, a variety of indications have been described. Intrauterine transfusion (IUT) treatment is considered most successful for fetal anemia due to red cell alloimmunization. Moreover, the use of this procedure has also been reported in pregnancies with parvovirus B19 infection, fetomaternal hemorrhage and placental chorioangiomas, for example. This review focuses on the current indications of intrauterine blood transfusions. In addition, we describe the potential complications of IUT treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research